In a mixed market, investors continue to search for stocks with strong analyst backing and meaningful upside. The three companies below each have a Strong Buy consensus and an average price target, suggesting at least 40% potential gains over the next year. They operate in digital advertising, networking, and cloud contact center software, with analysts pointing to solid growth prospects.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Viant Technology
First on the list is Viant Technology (DSP), a digital advertising company that offers a cloud-based demand-side platform called Adelphic. The platform allows marketers to plan, buy, and measure ads across desktop, mobile, connected TV, and other channels. The stock is down over 30% year-to-date, but analysts see a rebound ahead.
The highest price target is $26.00, while the average is $23.00, indicating strong potential gains. In the last three months, all six analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 73%.
Innodata
Innodata (INOD) is a data engineering company that delivers AI-driven digital transformation services. Its work includes data annotation, enrichment, and knowledge process outsourcing for businesses in the technology, content, and analytics sectors. The stock has fallen over 13% in the past five days, yet analysts remain confident in its long-term trajectory, with the stock up nearly 13% year-to-date.
The highest price target is $75.00, while the average is $63.40. In the last three months, all five analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 42%.
Five9
Five9 (FIVN) develops cloud contact center software that helps companies manage customer interactions across voice, chat, email, and social channels. The company serves clients in industries including finance, healthcare, and technology. The stock is down 36% year-to-date, but analysts highlight its recurring revenue model and expansion opportunities.
The highest price target is $59.00, with the average at $37.46. In the last three months, 13 of 15 analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 44%.
